Physician profile
Marc Bernstein
NPI 1851333587
$16,082.52
in general payments reported to CMS, 2019-2025
61 companies · $1,973 in 2025
The $1,973 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $2,556 · 2020: $1,495 · 2021: $2,764 · 2022: $2,129 · 2023: $3,285 · 2024: $1,880 · 2025: $1,973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,928 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,200 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,927.63 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,200.00 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,062.79 | 2019-2025 | |
| Pfizer INC. | $1,329.83 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,217.78 | 2019-2024 | Xarelto |
| Acarix USA INC. | $1,200.00 | 2023 | Cadscor System |
| E.R. Squibb & Sons, L.L.C. | $1,017.16 | 2019-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $933.92 | 2021-2025 | Linq II, Selectsecure, Azure Xt Dr Mri Surescan |
| Astrazeneca Pharmaceuticals Lp | $920.98 | 2019-2024 | Farxiga, Fasenra, Bevespi Aerosphere |
| Amgen INC. | $767.50 | 2019-2025 | Repatha, Repatha |
| Philips North America LLC | $712.20 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $675.36 | 2021-2025 | Verquvo, Belsomra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $495.59 | 2019-2025 | Jardiance |
| Esperion Therapeutics, INC. | $409.65 | 2020-2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $398.01 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $383.43 | 2021-2025 | |
| Novo Nordisk INC | $373.49 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $371.18 | 2019-2025 | Mounjaro |
| Amarin Pharma, INC. | $252.85 | 2019-2022 | |
| Astellas Pharma US INC | $178.55 | 2021 | |
| Impulse Dynamics (USA) INC. | $169.52 | 2021 | |
| Boston Scientific Corporation | $156.84 | 2021-2025 | Watchman Flx, Watchman Access System, Watchman |
| Regeneron Healthcare Solutions, INC. | $149.36 | 2019-2024 | Evkeeza |
| Biotronik INC. | $130.36 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $126.20 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $125.26 | 2021-2023 | Uptravi |
| Arbor Pharmaceuticals, INC. | $121.45 | 2019-2021 | |
| Abbott Laboratories | $113.49 | 2025 | Freestyle Libre 3 |
| Valeritas, INC. | $109.60 | 2019 | |
| Scpharmaceuticals INC. | $105.15 | 2023-2025 | |
| Glaxosmithkline, LLC. | $96.41 | 2019-2022 | |
| Itamar Medical INC | $94.69 | 2023-2025 | Watchpatone |
| Covidien Lp | $86.81 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $81.16 | 2023-2024 | Inpefa |
| Tactile Systems Technology INC | $67.20 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Lundbeck LLC | $62.86 | 2019-2020 | |
| Irhythm Technologies, INC. | $59.69 | 2022 | |
| United Therapeutics Corporation | $59.69 | 2019-2023 | Tyvaso |
| Cvrx, INC. | $42.20 | 2023-2024 | Barostim Neo System |
| Otsuka America Pharmaceutical, INC. | $39.79 | 2019 | |
| Medtronic Vascular, INC. | $38.57 | 2019 | |
| Sanofi Pasteur INC. | $29.75 | 2020 | |
| Dexcom, INC. | $29.36 | 2025 | Dexcom G6 Transmitter |
| Cook Medical LLC | $28.72 | 2025 | Zilver Ptx |
| Amryt Pharma Holdings Ltd | $28.40 | 2022 | |
| Nuwellis, INC. | $27.98 | 2020 | |
| Celonova Biosciences, INC. | $22.88 | 2019 | |
| Kiniksa Pharmaceuticals, Ltd. | $22.67 | 2023 | Arcalyst |
| Gilead Sciences, INC. | $21.92 | 2019 | |
| Medicomp INC | $20.59 | 2024 | Telepatch Cardiac Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.11 | 2021 | |
| Azurity Pharmaceuticals, INC. | $19.10 | 2024 | Edarbi |
| Silk Road Medical, INC. | $18.13 | 2019 | |
| Cardiva Medical, INC. | $16.29 | 2023 | Cardiva Vascade 6/7f Vcs |
| Baxter Healthcare | $13.64 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Cardiovascular Systems INC. | $12.63 | 2019 | |
| Convatec INC. | $12.04 | 2022 | |
| Bardy Diagnostics, INC. | $1.74 | 2020 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$45,424.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.